Your Messages Inbox
Your Article Summary
See Latest ArticlesImmunoGen, Inc. Announces Proposed Public Offering of Common Stock
ImmunoGen, Inc., 06/18/09
ImmunoGen, Inc. , a biopharmaceutical company that develops targeted anticancer therapeutics, announced today that it intends to offer, subject to market and other conditions, 5,000,000 shares of its common stock in an underwritten public offering. ImmunoGen expects to grant the underwriters a thirty day option to purchase up to 750,000 additional shares to cover over-allotments, if any.
Today in Popular Press...keeping you current
Receive free subspecialty "5-minute updates" via email
Heinrich Wieland Prize 2009 awarded for outstanding achievements in the synthesis of key natural products
Boehringer Ingelheim, 10/30/09
Nobel Prize team includes three hospital researchers
American Hospital Association News, 10/14/09
Call for Applications: The Amgen Award for Science Teaching Excellence
Amgen, 11/05/09
Article Search
Sponsor